AlphaStocks

PEN vs VAL

As of Sep 20, 2026, Penumbra (PEN) scores 4.1/10 and Valaris (VAL) 4.6/10 on AlphaStocks' five-model composite, so VAL scores higher.

PEN

Penumbra Inc

4.1

Weak

$317.56

VAL

Valaris Ltd

4.6

Weak

$83.77

PEN vs VAL: Which is the Better Investment?

Penumbra Inc (PEN) scores 4.1/10 while Valaris Ltd (VAL) scores 4.6/10 on AlphaStocks' composite model. Valaris Ltd has the higher composite rating of Weak. On a P/E basis, Valaris Ltd trades at 6.0x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricPENVAL
Scores & Fundamentals
Composite Score4.1/104.6/10
RatingWeakWeak
Price$317.56$83.77
P/E Ratio70.26.0
ROE12.8%35.0%
Market Cap$13B$6B
Fair Value
Dividend Yield
Sector Rank#138 of 168#37 of 80
Model Verdicts
PiotroskiAttractiveStrong
BuffettAttractiveAttractive
GrahamCautionNeutral
LynchLimited DataNeutral
GreenblattLimited DataAttractive
View full PENanalysis →View full VALanalysis →

Related comparisons

Compare any two stocks →

PEN vs VAL: Which Stock Scores Higher?

Penumbra Inc (PEN) is in the Health Care sector; Valaris Ltd (VAL) is in Energy. VAL currently leads with a composite score of 4.6/10 (Weak) compared to PEN's 4.1/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer